The global In Vitro Diagnostics (IVD) Quality Control market gathered revenue around USD 1.0 Billion in 2020 and market is set to grow USD 2.9 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 6.2% during the prediction period 2021 to 2027.
The global In Vitro Diagnostics (IVD) Quality Control market gathered revenue around USD 1.0 Billion in 2020 and market is set to grow USD 2.9 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 6.2% during the prediction period 2021 to 2027.
Request Free Sample of This Report@ https://www.novaoneadvisor.com/report/sample/5780
The In Vitro Diagnostics (IVD) Quality Control testing plays a significant role in clinical decision-making. Over the years, In Vitro Diagnostics (IVD) Quality Control quality control products and procedures have become mandatory in accredited clinical or medical laboratories. The applications of In Vitro Diagnostics (IVD) Quality Control quality control products have also widened over the years, with a number of quality controls currently available in the market for clinical chemistry, immunochemistry, hematology, molecular diagnostics, coagulation, and microbiology. To ensure technological competitiveness, companies are continuously launching innovative and advanced quality control products in the market for a variety of applications.
The growth of the In Vitro Diagnostics Quality Control Market is primarily driven by the rising number of accredited clinical laboratories, rising geriatric population, rising demand for external quality assessment programs, increasing adoption of and POC instruments in developed regions and increasing adoption of third-party quality controls. The rising focus on multi-analyte controls is also expected to offer significant growth opportunities for the market in the coming years. The use of quality control products is, however, not mandatory for all clinical laboratories in many countries. The lack of regulations for these products is expected to adversely affect market growth.
Ask here for more customization study@ https://www.novaoneadvisor.com/report/customization/5780
Report Coverage
| Report Scope | Details |
| Market Size | USD 2.9 Billion by 2027 |
| Growth Rate | CAGR of 6.2% From 2021 to 2027 |
| Base Year | 2020 |
| Forecast Period | 2021 to 2027 |
| Historic Data | 2017 to 2020 |
| Report coverage | Growth Factors, Revenue Status, Competitive Landscape, and Future Trends |
| Segments Covered | By product, technology, manufacturer type, and end user and region |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
Regional analysis:
North America was the largest regional market in 2020 and accounted for a revenue share of 46.59% owing to the presence of the U.S. FDA and many accredited diagnostic laboratories coupled with strong QC regulation systems. U.S. FDA along with GHTF regulates the North America region for the IVD QC market, from the production to pre- and post-marketing surveillance. The Asia Pacific is expected to be the fastest-growing region over the forecast period as the region has a high potential for this market due to the increasing number of product manufacturing companies.
Moreover, the Asia Pacific Federation of Clinical Biochemistry and Laboratory Medicine (APFCB) has been encouraging the use of IVDs. Thus, a rise in awareness for early and precise diagnosis fosters the product demand. Also, the presence of key regulatory authorities in the region, such as the Ministry of Health, Labor and Welfare (MHLW), Pharmaceuticals and Medical Devices Evaluation Agency (PMDA), and Ministry of Agriculture and Fisheries and Food, will support the market growth.
Some of the prominent players in the In Vitro Diagnostics (IVD) Quality Control Market include: Bio-Rad Laboratories, Inc., Randox Laboratories Ltd., Thermo Fisher Scientific, Inc., LGC Limited, and Abbott Laboratories. Roche Diagnostics, Siemens Healthineers, Danaher Corporation, Fortress Diagnostics, SERO AS, Sysmex Corporation, Ortho-Clinical Diagnostics, Helena Laboratories Corporation, Quidel Corporation, Sun Diagnostics, LLC, Seegene Inc., ZeptoMetrix Corporation, Qnostics, Bio-Techne Corporation, Microbiologics, Microbix Biosystems, Streck, Inc., Alpha-Tec Systems, Maine Molecular Quality Controls, Inc..
Unravelling the Critical Segments
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:
Global IVD quality control market, by product and service
- Quality control products
- Serum/ Plasma based controls
- Whole blood based controls
- Urine based controls
- Other controls
- Data Management Solutions
- Quality Assurance Services
Global IVD quality control market, by technology
- Immunochemistry
- Clinical Chemistry
- Molecular Diagnostics
- Microbiology
- Hematology
- Coagulation/ Hemostasis
- Other Technologies
Global IVD quality control market, by manufacturer type
- Third-party controls
- Independent controls
- Instrument specific controls
- Original Equipment Manufacturer controls
Global IVD quality control market, by end user
- Hospitals
- Clinical Laboratories
- Academic and Research Institutes
- Other End users
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Key Benefits for Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the global In Vitro Diagnostics (IVD) Quality Control industry analysis from 2022 to 2030 to identify the prevailing In Vitro Diagnostics (IVD) Quality Control industry opportunity.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the global In Vitro Diagnostics (IVD) Quality Control industry segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global In Vitro Diagnostics (IVD) Quality Control industry trends, key players, market segments, application areas, and market growth strategies.
Full Report is Ready | For Purchase Inquiry@ https://www.novaoneadvisor.com/report/checkout/5780
You can place an order or ask any questions, please feel free to sales@novaoneadvisor.com| +1 9197 992 333
Blog: https://www.novaoneadvisor.com/
Blog: https://www.visionresearchreports.com/
Blog: https://qyresearchmedical.com/